Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen Yadav

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Journal of Biological Chemistry|April 10, 2021
Correction: Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivoSweety Samal, Tripti Shrivastava, Praveen Sonkusre, et al.
Frontiers in Immunology|April 12, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses <i>in vivo</i> and Inhibit Viral Replication <i>in vitro</i>Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, et al.
The Journal of Biological Chemistry|August 21, 2020
Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity <i>in vivo</i>Sweety Samal, Tripti Shrivastava, Praveen Sonkusre, et al.
The Journal of Biological Chemistry|July 31, 2020
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic libraryHilal Ahmad Parray, Adarsh Kumar Chiranjivi, Shailendra Asthana, et al.
The Indian Journal of Medical Research|June 1, 2020
A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020Jeromie Wesley Vivian Thangaraj, Manoj Murhekar, Yatin Mehta, et al.
Iscience|January 1, 2024
More time to kill: A longer liver stage increases T cell-mediated protection against pre-erythrocytic malariaNaveen Yadav, Chaitra Parthiban, Zachary P Billman, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Journal of Biological Chemistry|April 10, 2021
Correction: Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivoSweety Samal, Tripti Shrivastava, Praveen Sonkusre, et al.
Frontiers in Immunology|April 12, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses <i>in vivo</i> and Inhibit Viral Replication <i>in vitro</i>Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, et al.
The Journal of Biological Chemistry|August 21, 2020
Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity <i>in vivo</i>Sweety Samal, Tripti Shrivastava, Praveen Sonkusre, et al.
The Journal of Biological Chemistry|July 31, 2020
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic libraryHilal Ahmad Parray, Adarsh Kumar Chiranjivi, Shailendra Asthana, et al.
The Indian Journal of Medical Research|June 1, 2020
A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020Jeromie Wesley Vivian Thangaraj, Manoj Murhekar, Yatin Mehta, et al.
Iscience|January 1, 2024
More time to kill: A longer liver stage increases T cell-mediated protection against pre-erythrocytic malariaNaveen Yadav, Chaitra Parthiban, Zachary P Billman, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
Pageof 7